Horizon Therapeutics plc Announces EB Research Partnership Receives 2022 Horizon Prize, Powered by MIT Solve
--Organization Will Utilize GPS and Web Services to Build a Patient-Driven Platform for the Epidermolysis Bullosa (EB) Community and Accelerate a Cure -- Horizon Therapeutics plc (Nasdaq: HZNP), in
Source: finanznachrichten.de